ES309809A1 - Pharmaceutical composition containing 1-(4-hydroxyphenyl)-2-{2-(4-hydroxyphenyl)ethylamino}-propanol and salts thereof - Google Patents
Pharmaceutical composition containing 1-(4-hydroxyphenyl)-2-{2-(4-hydroxyphenyl)ethylamino}-propanol and salts thereofInfo
- Publication number
- ES309809A1 ES309809A1 ES0309809A ES309809A ES309809A1 ES 309809 A1 ES309809 A1 ES 309809A1 ES 0309809 A ES0309809 A ES 0309809A ES 309809 A ES309809 A ES 309809A ES 309809 A1 ES309809 A1 ES 309809A1
- Authority
- ES
- Spain
- Prior art keywords
- hydroxyphenyl
- ethylamino
- propanol
- salts
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- IOVGROKTTNBUGK-UHFFFAOYSA-N 4-[2-[[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol Chemical compound C=1C=C(O)C=CC=1C(O)C(C)NCCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001813 broncholytic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 p - hydroxyphenyl Chemical group 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/10—Mercury compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Racemic and optically active 1-(p-hydroxyphenyl) - 2 - [21 - (p - hydroxyphenyl) - ethylamino] propanol and acid addition salts thereof are prepared by standard methods, such as reducing an aminoketone of the general formula <FORM:1111451/C2/1> (wherein Y and Y1 represent hydroxy or etherified or esterified hydroxy groups) or an acid addition salt thereof and hydrolysing or hydrogenolysing the product if necessary, optionally followed by salt formation, separation of a mixture of the racemates and/or resolution. The preparation of aminoketones of the above general formula is described. The compounds of the invention possess uterospasmolytic and broncholytic activity, and may be administered in the form of pharmaceutical preparations containing them together with a carrier.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL6401871A NL6401871A (en) | 1964-02-27 | 1964-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES309809A1 true ES309809A1 (en) | 1965-07-01 |
Family
ID=19789406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0309809A Expired ES309809A1 (en) | 1964-02-27 | 1965-02-25 | Pharmaceutical composition containing 1-(4-hydroxyphenyl)-2-{2-(4-hydroxyphenyl)ethylamino}-propanol and salts thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3410944A (en) |
| AT (4) | AT264502B (en) |
| BE (1) | BE660244A (en) |
| BR (1) | BR6567446D0 (en) |
| CH (3) | CH539604A (en) |
| DE (1) | DE1293782B (en) |
| DK (2) | DK118827B (en) |
| ES (1) | ES309809A1 (en) |
| FR (2) | FR1483718A (en) |
| GB (1) | GB1111451A (en) |
| NL (1) | NL6401871A (en) |
| SE (1) | SE339481B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1962497C3 (en) * | 1969-12-12 | 1979-09-20 | C.H. Boehringer Sohn, 6507 Ingelheim | Naphthylalkyl-a-hydroxyphenethyl-amines, their preparation and pharmaceuticals containing them |
| US4704407A (en) * | 1984-12-20 | 1987-11-03 | Eli Lilly And Company | Soluble dobutamine salts |
| MY126489A (en) | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| CN102060716A (en) * | 2009-11-15 | 2011-05-18 | 海南中化联合制药工业股份有限公司 | Ritodrine hydrochloride preparation method |
| IT1399912B1 (en) | 2010-04-29 | 2013-05-09 | Lundbeck Pharmaceuticals Italy S Pa | PREPARATION PROCESS FOR CHLORIDATED RITODRIN. |
| CN102976959B (en) * | 2012-12-07 | 2014-06-04 | 许学农 | Preparation method of ritodrine |
| US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
| EP4651867A1 (en) | 2023-01-20 | 2025-11-26 | Atrogi AB | Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting |
| GB202302225D0 (en) | 2023-02-16 | 2023-04-05 | Atrogi Ab | New medical uses |
| GB202303229D0 (en) | 2023-03-06 | 2023-04-19 | Atrogi Ab | New medical uses |
| GB202403169D0 (en) | 2024-03-05 | 2024-04-17 | Atrogi Ab | New medical uses |
| WO2025238248A1 (en) | 2024-05-17 | 2025-11-20 | Atrogi Ab | USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA623286A (en) * | 1961-07-04 | N.V. Philips Gloeilampenfabrieken | Production of optically active 1-(3',4'-dihydroxyphenyl)-2-amino ethanols | |
| NL86359C (en) * | ||||
| US2661373A (en) * | 1953-03-02 | 1953-12-01 | Kulz Ida | Certain amino alcohols and ketones |
| BE612995A (en) * | 1961-01-23 | 1962-07-23 | Philips Nv | Process for preparing a novel compound with optical activity |
| AT228786B (en) * | 1961-01-23 | 1963-08-12 | Philips Nv | Process for the preparation of the new (-) - enantiomer of 1- (p-hydroxyphenyl) -2- (α-methyl-γ-phenyl-propylamino) -propanols- (1) and its acid addition salts |
| US3250803A (en) * | 1961-07-06 | 1966-05-10 | Philips Corp | Method of manufacturing the individual racemates of n-(p-hydroxyphenylisopropyl) arterenol and products |
| NL302260A (en) * | 1963-01-24 | 1900-01-01 |
-
1964
- 1964-02-27 NL NL6401871A patent/NL6401871A/xx unknown
-
1965
- 1965-02-24 AT AT783767A patent/AT264502B/en active
- 1965-02-24 BR BR167446/65A patent/BR6567446D0/en unknown
- 1965-02-24 SE SE02385/65A patent/SE339481B/xx unknown
- 1965-02-24 AT AT783867A patent/AT268252B/en active
- 1965-02-24 AT AT922766A patent/AT270618B/en active
- 1965-02-24 DK DK95865AA patent/DK118827B/en unknown
- 1965-02-24 DE DEN26270A patent/DE1293782B/en active Pending
- 1965-02-24 CH CH1410468A patent/CH539604A/en not_active IP Right Cessation
- 1965-02-24 CH CH1410368A patent/CH503692A/en not_active IP Right Cessation
- 1965-02-24 AT AT161165A patent/AT261590B/en active
- 1965-02-24 CH CH249665A patent/CH472368A/en not_active IP Right Cessation
- 1965-02-25 ES ES0309809A patent/ES309809A1/en not_active Expired
- 1965-02-25 US US435344A patent/US3410944A/en not_active Expired - Lifetime
- 1965-02-25 GB GB8153/65A patent/GB1111451A/en not_active Expired
- 1965-02-25 BE BE660244A patent/BE660244A/xx unknown
- 1965-02-26 FR FR7240A patent/FR1483718A/en not_active Expired
- 1965-05-24 FR FR18183A patent/FR4404M/fr not_active Expired
-
1966
- 1966-11-30 DK DK619266AA patent/DK116740B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK118827B (en) | 1970-10-12 |
| FR1483718A (en) | 1967-06-09 |
| US3410944A (en) | 1968-11-12 |
| DE1293782B (en) | 1969-04-30 |
| FR4404M (en) | 1966-10-10 |
| SE339481B (en) | 1971-10-11 |
| CH539604A (en) | 1973-07-31 |
| AT270618B (en) | 1969-05-12 |
| NL6401871A (en) | 1965-08-30 |
| AT264502B (en) | 1968-09-10 |
| AT261590B (en) | 1968-05-10 |
| BR6567446D0 (en) | 1973-08-02 |
| GB1111451A (en) | 1968-04-24 |
| CH503692A (en) | 1971-02-28 |
| DK116740B (en) | 1970-02-09 |
| BE660244A (en) | 1965-08-25 |
| CH472368A (en) | 1969-05-15 |
| AT268252B (en) | 1969-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES309809A1 (en) | Pharmaceutical composition containing 1-(4-hydroxyphenyl)-2-{2-(4-hydroxyphenyl)ethylamino}-propanol and salts thereof | |
| SE329174B (en) | ||
| GB1147379A (en) | 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts | |
| ES8401960A1 (en) | Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them. | |
| IE34859L (en) | Isoquinolines. | |
| GB1289240A (en) | ||
| GB1434805A (en) | 5-phenoxy-4-amino pyrimidines | |
| GB1126002A (en) | New basic ethers and process for preparing same | |
| GB1043519A (en) | New basic alcohols | |
| GB1136918A (en) | Propanolamine derivatives | |
| GB1208231A (en) | beta-PHENETHYLAMINE DERIVATIVES AND A PROCESS FOR THE MANUFACTURE THEREOF | |
| GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
| GB1390329A (en) | Pyrazines | |
| IE34590L (en) | Phenylethanolamine derivatives | |
| GB1415682A (en) | Amides and thioamides | |
| GB1187546A (en) | Propanolamine derivatives | |
| SE333735B (en) | ||
| GB1160448A (en) | Alkanolamine Derivatives | |
| GB1442619A (en) | 3-phenoxypropylamine derivatives their preparation and use | |
| GB1353612A (en) | Process for the preparation of a glycine derivative | |
| GB1234967A (en) | Alkanolamine derivatives | |
| GB1342643A (en) | Thioacetanilide derivatives | |
| GB1211459A (en) | Hydroxy amines | |
| GB1138968A (en) | Improvements in or relating to indole derivatives | |
| SE8105340L (en) | NEW 4-CARBAMOYLOXIOXAZAPHOSPHORINES AND PROCEDURES FOR PREPARING THEREOF |